周二美股市场涨跌互现之际，Catalyst Pharmaceutical Partners（CPRX）股价逆势下挫3.10%，收报20.95美元。尽管纳斯达克综合指数微升0.18%至20,677.80点，道琼斯工业平均指数却下挫0.98%收于44,023.29点，凸显市场分化格局。
此次下跌标志着该股连续第三个交易日收阴。当前股价较6月9日创下的52周高点26.58美元仍有21.18%的差距，上行压力显著。
横向对比同业表现，CPRX颓势尤为突出：强生（JNJ）下跌1.05%至155.17美元；辉瑞（PFE）下挫2.92%收于24.61美元；雅培（ABT）则逆势微涨0.04%，报131.49美元。
值得关注的是，当日140万股成交总量已突破其50日平均成交量130万股，显示市场交投活跃度提升。当前股价持续承压态势与放量下跌的技术形态，为投资者敲响风险警钟。
（数据截至2025年7月15日）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.